Third Arc Bio

Powering Superior Immune Synapses

Spring House, United States · Founded 2022 · $217.0M raised

Founded
2022
Business Model
B2B
Total Funding
$217.0M
Last Round
$52.0M Extension RoundFeb 2026
Rounds
2

About

Third Arc Bio is a biopharmaceutical company advancing antibody technology by harnessing the biology of immune synapses to address solid tumors and autoimmune diseases. The company is developing next-generation immunotherapies targeting indications with significant unmet need.

Summary

Third Arc Bio is a Biotech company based in Spring House, United States, founded in 2022. It has raised $217.0M in total across 2 rounds, most recently a $52.0M Extension Round round in Feb 2026. Investors include Andreessen Horowitz.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A ExtensionFeb 2026
$52.0M

Sign up to see all 2 rounds

Series A through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Third Arc Bio on Indexed.vc
<a href="https://indexed.vc/companies/third-arc-bio"><img src="https://indexed.vc/api/badge/company/third-arc-bio" alt="Third Arc Bio on Indexed.vc" width="260" height="76" /></a>